Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.rights.licenseReconocimiento 4.0 Internacional. (CC BY)-
dc.contributor.authorRiera, Nadiaes
dc.contributor.authorParada, Andréses
dc.contributor.authorPeñalba, Florenciaes
dc.contributor.authorFlorez, Valeriaes
dc.contributor.authorElgul, Nabilaes
dc.contributor.authorPittini, Álvaroes
dc.contributor.authorMeyer, Carloses
dc.contributor.authorCawen, María Lauraes
dc.contributor.authorFerrari, Aracelyes
dc.contributor.authorLaureiro, Elenaes
dc.contributor.authorAlonso, Maria Isabeles
dc.contributor.authorMalvasio, Silvinaes
dc.contributor.authorBerois, Noraes
dc.contributor.authorOsinaga, Eduardoes
dc.contributor.authorIraola, Gregorioes
dc.date.accessioned2025-05-08T14:46:34Z-
dc.date.available2025-05-08T14:46:34Z-
dc.date.issued2023-06-
dc.identifier.urihttps://hdl.handle.net/20.500.12381/3961-
dc.description.abstractHuman gut microbiome is highly influenced by environmental factors, the host lifestyle and the geographic region. Efforts to understand the role of the gut microbiome in cancer on a local scale are needed to incorporate this knowledge in the clinic. We recruited 25 patients (melanoma, renal cell carcinoma, non-small cell lung cancer, and head and neck squamous cell carcinoma) and we aimed to characterize the diversity of the microbiota. Using shotgun metagenomics and culture-based tools we profiled the microbial composition of our uruguayan cohort. We compared the taxonomic diversity, gene families and metabolic pathways of our oncologic cohort with a healthy reference (n = 68). The microbial composition of the oncologic cohort differs from that of the healthy control. Our results show higher relative abundance of Enterococcus faecium and Klebsiella pneumoniae as compared to healthy individuals. Using culture-based techniques, we began the first Uruguayan microbial biobank from the gut microbiome.es
dc.description.sponsorshipAgencia Nacional de Investigación e Innovación (ANII)es
dc.description.sponsorshipGlaxoSmithKline Uruguayes
dc.description.sponsorshipFondo para la Convergencia Estructural del MERCOSUR (FOCEM)es
dc.description.sponsorshipWellcome Sanger Institutees
dc.language.isoenges
dc.relation.urihttps://hdl.handle.net/20.500.12381/3956es
dc.relation.urihttps://hdl.handle.net/20.500.12381/3957es
dc.relation.urihttps://hdl.handle.net/20.500.12381/3958es
dc.relation.urihttps://hdl.handle.net/20.500.12381/3959es
dc.relation.urihttps://hdl.handle.net/20.500.12381/3960es
dc.rightsAcceso abierto*
dc.sourceCell Symposia: Infection biology in the age of the microbiomees
dc.subjectMicrobiomaes
dc.subjectMetagenómicaes
dc.subjectInmunoterapiaes
dc.titleCancer-triggered gut dysbiosis in a uruguayan cohortes
dc.typeDocumento de conferenciaes
dc.subject.aniiCiencias Médicas y de la Salud
dc.identifier.aniiFSGSK_1_2019_1_159546es
dc.type.versionPublicadoes
dc.anii.institucionresponsableInstitut Pasteur de Montevideoes
dc.anii.institucionresponsableSindicato Médico del Uruguayes
dc.anii.subjectcompleto//Ciencias Médicas y de la Saludes
Aparece en las colecciones: Institut Pasteur de Montevideo

Archivos en este ítem:
archivo  Descripción Tamaño Formato
Cell-Symposia2023.pdfDescargar 68.77 kBAdobe PDF

Las obras en REDI están protegidas por licencias Creative Commons.
Por más información sobre los términos de esta publicación, visita: Reconocimiento 4.0 Internacional. (CC BY)